ZBTB37 Activators constitute a specialized category of chemical compounds that have attracted attention in the field of molecular biology and gene regulation. These activators are designed to modulate the activity of the ZBTB37 gene, where ZBTB37 stands for Zinc Finger and BTB Domain Containing 37. This gene is a protein-coding element found in humans, and it encodes a transcription factor that plays a pivotal role in the regulation of gene expression. ZBTB37 Activators represent a group of molecules engineered to enhance or stimulate the expression and function of the ZBTB37 gene, ultimately leading to an increase in the activity of the associated transcription factor.
The mechanism of action of ZBTB37 Activators typically involves their interaction with specific regulatory elements within the ZBTB37 gene, such as promoter regions or enhancer sequences. These interactions facilitate the upregulation of gene transcription, resulting in heightened synthesis of the ZBTB37 protein. ZBTB37 is known to be involved in the regulation of various genes, influencing diverse cellular processes, including cell cycle progression, DNA repair, and immune responses. As researchers continue to explore the functions and potential implications of ZBTB37 activation, the development and refinement of ZBTB37 Activators hold promise for advancing our understanding of gene regulation, cellular biology, and the broader role of ZBTB37 in orchestrating gene expression, potentially revealing novel aspects of genetic control and cellular responses.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin may influence gene expression by interfering with DNA replication and repair mechanisms, potentially affecting transcription factor activity. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases and may affect cell cycle-dependent gene expression, potentially including ZBTB37. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib affects the proteasome pathway, potentially influencing the degradation of transcriptional repressors and activating gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat is a histone deacetylase inhibitor that can lead to a relaxed chromatin state and potentially upregulate genes like ZBTB37. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to heat shock protein 90 (Hsp90), potentially altering the stability and function of several client proteins, including transcription factors. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, which may affect the transcriptional programs of numerous genes, possibly including ZBTB37. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can modulate various cellular pathways, including the proteasome, which may impact transcription factor activity and gene expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA and can inhibit transcription factor binding, affecting gene expression profiles, including ZBTB37. | ||||||
Oxamflatin | 151720-43-3 | sc-205960 sc-205960A | 1 mg 5 mg | $151.00 $470.00 | 4 | |
Oxamflatin is a histone deacetylase inhibitor that can change gene expression by affecting chromatin structure. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide affects multiple signaling pathways and may alter the transcription of a wide array of genes by influencing transcription factor activity. | ||||||